Thursday, Oct. 17, 2013
ATHENS, Ga. (WRDW) -- New medicine developed at the University of Georgia is said to attack HIV before it integrates with human DNA, according to a press release.
"In our laboratories, we have discovered a highly potent HIV integrase inhibitor, or blocker, aimed at the ‘point of no return' in HIV infectivity," said Nair, who is the Georgia Research Alliance Eminent Scholar in Drug Discovery in the UGA College of Pharmacy. "This inhibitor is highly effective against many variations of HIV."
The therapy is now in the pre-clinical testing phase.
The research was funded through the Division of AIDS in the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Results were recently published in the journal Antiviral Research.